JPMorgan Chase & Co. lifted its position in DocGo Inc. (NASDAQ:DCGO - Free Report) by 151.1% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 109,855 shares of the company's stock after purchasing an additional 66,097 shares during the quarter. JPMorgan Chase & Co. owned 0.11% of DocGo worth $365,000 at the end of the most recent reporting period.
Several other large investors have also made changes to their positions in DCGO. Harbor Capital Advisors Inc. grew its holdings in shares of DocGo by 144.6% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 968,537 shares of the company's stock worth $3,216,000 after purchasing an additional 572,522 shares during the last quarter. Marshall Wace LLP grew its holdings in DocGo by 212.4% during the 2nd quarter. Marshall Wace LLP now owns 505,514 shares of the company's stock worth $1,562,000 after acquiring an additional 343,692 shares during the last quarter. AQR Capital Management LLC grew its holdings in DocGo by 58.5% during the 2nd quarter. AQR Capital Management LLC now owns 344,963 shares of the company's stock worth $1,066,000 after acquiring an additional 127,320 shares during the last quarter. Franklin Resources Inc. grew its holdings in DocGo by 11.6% during the 3rd quarter. Franklin Resources Inc. now owns 1,199,086 shares of the company's stock worth $3,933,000 after acquiring an additional 124,348 shares during the last quarter. Finally, Point72 Asset Management L.P. grew its holdings in DocGo by 1,655.7% during the 2nd quarter. Point72 Asset Management L.P. now owns 116,844 shares of the company's stock worth $361,000 after acquiring an additional 110,189 shares during the last quarter. Institutional investors own 56.44% of the company's stock.
Insiders Place Their Bets
In other news, General Counsel Ely D. Tendler sold 23,088 shares of the firm's stock in a transaction that occurred on Monday, December 16th. The shares were sold at an average price of $4.44, for a total transaction of $102,510.72. Following the completion of the transaction, the general counsel now directly owns 175,645 shares of the company's stock, valued at $779,863.80. This trade represents a 11.62 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 2.70% of the company's stock.
DocGo Stock Performance
DocGo stock traded up $0.05 during trading hours on Thursday, reaching $4.85. 382,157 shares of the company's stock traded hands, compared to its average volume of 419,250. DocGo Inc. has a fifty-two week low of $2.75 and a fifty-two week high of $5.05. The firm has a market capitalization of $494.94 million, a price-to-earnings ratio of 17.32, a PEG ratio of 12.36 and a beta of 0.97. The firm's 50 day moving average is $4.31 and its 200-day moving average is $3.78.
DocGo (NASDAQ:DCGO - Get Free Report) last announced its quarterly earnings results on Thursday, November 7th. The company reported $0.05 earnings per share for the quarter, beating analysts' consensus estimates of $0.04 by $0.01. The business had revenue of $138.68 million for the quarter, compared to the consensus estimate of $139.59 million. DocGo had a net margin of 4.35% and a return on equity of 8.90%. During the same period last year, the company posted $0.05 EPS. Analysts predict that DocGo Inc. will post 0.25 EPS for the current year.
Wall Street Analysts Forecast Growth
Separately, Needham & Company LLC reissued a "buy" rating and set a $7.00 price objective on shares of DocGo in a report on Thursday, January 16th. Five equities research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company presently has an average rating of "Buy" and a consensus price target of $6.10.
Get Our Latest Analysis on DocGo
DocGo Profile
(
Free Report)
DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.
See Also
Before you consider DocGo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocGo wasn't on the list.
While DocGo currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.